These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2473774)

  • 1. Low maternal serum alpha-fetoprotein at 10 weeks gestation and fetal Down's syndrome.
    Mantingh A; Marrink J; de Wolf B; Breed AS; Beekhuis JR; Visser GH
    Br J Obstet Gynaecol; 1989 Apr; 96(4):499-500. PubMed ID: 2473774
    [No Abstract]   [Full Text] [Related]  

  • 2. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for Down's syndrome using an iso-risk curve based on maternal age and serum alpha-fetoprotein level.
    Tabor A; Larsen SO; Nielsen J; Nielsen J; Philip J; Pilgaard B; Videbech P; Nørgaard-Pedersen B
    Br J Obstet Gynaecol; 1987 Jul; 94(7):636-42. PubMed ID: 2441737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
    Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA
    Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal serum alpha-fetoprotein screening and Down's syndrome.
    Wu LR
    Am J Obstet Gynecol; 1986 Dec; 155(6):1362-3. PubMed ID: 2431621
    [No Abstract]   [Full Text] [Related]  

  • 6. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An alpha-fetoprotein radioimmunoassay for use in maternal serum screening for Down's syndrome: limitations and improvements.
    Mooney RA; McGorty BL; French CA; Arvan DA
    Clin Chim Acta; 1988 Feb; 171(2-3):325-31. PubMed ID: 2453312
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening of maternal serum for fetal Down's syndrome in the first trimester.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A
    N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal alpha-fetoprotein screening for Down's syndrome.
    Pueschel SM
    N Engl J Med; 1987 Aug; 317(6):376-8. PubMed ID: 2439910
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels.
    DiMaio MS; Baumgarten A; Greenstein RM; Saal HM; Mahoney MJ
    N Engl J Med; 1987 Aug; 317(6):342-6. PubMed ID: 2439909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening by maternal serum markers for Down's syndrome].
    Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome].
    Liao S; Wang Y; Ye G
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome.
    Wald NJ; Cuckle HS; Densem JW; Nanchahal K; Canick JA; Haddow JE; Knight GJ; Palomaki GE
    Br J Obstet Gynaecol; 1988 Apr; 95(4):334-41. PubMed ID: 2454652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down's syndrome: current screening techniques.
    White RS
    South Med J; 1989 Dec; 82(12):1483-6. PubMed ID: 2480649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving methods of screening for Down's syndrome.
    White I; Papiha SS; Magnay D
    N Engl J Med; 1989 Feb; 320(6):401-2. PubMed ID: 2464139
    [No Abstract]   [Full Text] [Related]  

  • 16. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical screening for Down's syndrome.
    Holding S
    BMJ; 1991 May; 302(6787):1275. PubMed ID: 1710521
    [No Abstract]   [Full Text] [Related]  

  • 18. Antenatal screening for Down's syndrome.
    Spencer K; Macri JN; Coombes EJ; Ward AM
    BMJ; 1993 Jun; 306(6892):1616. PubMed ID: 7687179
    [No Abstract]   [Full Text] [Related]  

  • 19. Repeat maternal serum alpha-fetoprotein testing in antenatal screening programmes for Down's syndrome.
    Cuckle HS; Wald NJ; Nanchahal K; Densem J
    Br J Obstet Gynaecol; 1989 Jan; 96(1):52-60. PubMed ID: 2466479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight.
    Wald NJ; Cuckle HS; Densem JW; Kennard A; Smith D
    Br J Obstet Gynaecol; 1992 Feb; 99(2):144-9. PubMed ID: 1372820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.